Your search returned 26 results
… $ 68 $ 86 $ 675 $ 356 EBITDA $ 133 $ 162 $ 955 $ 534 EBITDA margin 14% … 2022, free cash flow was $2,287 million, an increase of $551 million as compared to the full year of 2021 due to the … income from operations of $2,416 million decreased by $133 million as compared to income from operations of $2,549 …
… margin 14% 7% 15% EBITDA $ 205 $ 133 $ 258 EBITDA margin 20% 14% 21% … 71 Other income, net 8 7 2 EBITDA $ 133 $ 205 $ 258 Net external sales $ 938 $ …
… margin 14% 7% 15% EBITDA $ 205 $ 133 $ 258 EBITDA margin 20% 14% 21% … 71 Other income, net 8 7 2 EBITDA $ 133 $ 205 $ 258 Net external sales $ 938 $ …
… quarter of 2012. The company reported Adjusted EBITDA of $133.4 million in the first quarter of 2013, compared to … $ 0.75 $ 0.79 Adjusted EBITDA $ 133.4 $ 75.4 “During the first quarter, we completed … $ 134.2 $ (2.6 ) $ 13.3 $ (11.5 ) $ 133.4 Transaction related costs and other, net …
… $ 68 $ 710 $ 675 EBITDA $ 173 $ 327 $ 133 $ 949 $ 955 EBITDA margin 18% 29% … 8 32 17 EBITDA $ 327 $ 173 $ 133 $ 949 $ 955 Net external sales $ 1,144 $ …
… $ 68 $ 710 $ 675 EBITDA $ 173 $ 327 $ 133 $ 949 $ 955 EBITDA margin 18% 29% … 8 32 17 EBITDA $ 327 $ 173 $ 133 $ 949 $ 955 Net external sales $ 1,144 $ …
… $ 68 $ 710 $ 675 EBITDA $ 173 $ 327 $ 133 $ 949 $ 955 EBITDA margin 18% 29% … 8 32 17 EBITDA $ 327 $ 173 $ 133 $ 949 $ 955 Net external sales $ 1,144 $ …
… the first quarter of 2014, compared to Adjusted EBITDA of $133.4 million for the first quarter of the prior year. “Our … ) $ 0.75 Adjusted EBITDA $ 67.6 $ 133.4 Chlorovinyls In the Chlorovinyls … $ 134.2 $ (2.6 ) $ 13.3 $ (11.5 ) $ 133.4 Costs to attain Merger-related synergies (0.7 ) …